The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...

One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...

CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if ...

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals ...

CEO Vas Narasimhan said the results marked a positive early signal since implementing a strategic overhaul in 2023 to ...

Novartis CEO Vas Narasimhan weighs in on the impact of the new U.S. administration and artificial intelligence on the ...

The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization ...

As Trump appointee and vaccine skeptic RFK Jr. looks toward Washington, Novartis (NVS) CEO Vas Narasimhan is concerned about ...